AlphAIAlphAI — Financial news for AI agents
gurufocus.comSEP 11 min read$ALGN

Align Technology (ALGN) Appoints Quentin Blackford to Board of D

Align Technology (ALGN) appointed Quentin Blackford to its board, expanding it to 11 members. Andrea Saia will resign as a director on September 23, 2026, reducing the board to 10. Blackford will stand for election in 2027 and receive prorated compensation. GuruFocus estimates ALGN's fair value at $224.35, indicating a 28.8% undervaluation.

Original reporting
gurufocus.com
Published Sep 1, 2026, 8:46 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 11:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefCorporate actions
Primary signal
$ALGN
Neutral
high confidence
Mentioned
$ALGN
Relevance
4/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$ALGNNeutralLow
01

Why it matters

The board change is a standard corporate governance update with minimal market relevance.

02

Market read

Routine board reshuffle; unlikely to move the stock.

03

What to watch

Potential future board dynamics or upcoming shareholder votes.

Relevance 4/10Novelty 3/10Timing: announcement on Aug 27, 2026

Background

Align Technology is a leading provider of clear aligners and intraoral scanners.

Company-level read

Ticker impact

$ALGNNeutralHigh confidence
Context

Board appointment of Quentin Blackford and resignation of Andrea Saia disclosed; first public notice of the director change.

Expected impact

No significant move expected; price likely to remain flat.

Evidence & confidence

Director changes are routine and do not alter core business fundamentals.

Market effects

Sector

No material effect on the dental/orthodontic equipment sector.

Regional

Limited to U.S. investors; no broader regional impact.

Global

Negligible for global markets.

Counterpoint

What could challenge this read

If the new director brings strategic insight, a modest upside could emerge.

Key entities

  • Director
    Quentin Blackford

    Newly appointed board member.

  • Director
    Andrea L. Saia

    Resigning director effective Sep 23, 2026.

Read at source← All news

Related articles

SEP 1
$ALGNLow

Align Tech adds Quentin Blackford to board

Align Technology (ALGN) added Quentin Blackford, CEO of iRhythm Technologies, to its board, expanding it to 11 members. Blackford brings healthcare and digital innovation experience. Director Andrea L. Saia will retire in September 2026, reducing the board to 10 members.

theglobeandmail.com1 min
AUG 27
$ALGNMed

Are Wall Street Analysts Bullish on Align Technology Stock?

Align Technology (ALGN), a medical device company, has underperformed the broader market and healthcare sector ETF over the past 52 weeks. Analysts expect its adjusted EPS to grow 10.9% YoY by 2026, with a consensus 'Moderate Buy' rating. The mean price target is $207.07, implying a 30.1% upside. Piper Sandler maintained a 'Buy' rating with a $235 target.

barchart.com2 min
AUG 12
$ALGNMed

Align Technology Prevails in China Patent Infringement Action Against Angelalign

Align Technology said a Jinan Intermediate People’s Court issued a first-instance ruling on Aug. 10, 2026 in a China patent case against Angel. The court found Angel’s MasterForce and ATreat systems infringe Align’s CN113693748B patent and ordered Angel to stop use, manufacturing, and sales, awarding RMB 10 million in damages. Angel can appeal to China’s Supreme People’s Court.

antaranews.com4 min
AUG 12
$ALGNMed

Align Technology, Inc.: Align Technology Prevails in China Patent Infringement Action Against Angelalign

Align Technology (Nasdaq: ALGN) said China’s Jinan Intermediate People’s Court ruled in its favor in a patent infringement case against Angelalign’s China subsidiaries. The court found Angel infringed Align’s CN113693748B patent tied to extraction-gap-closure technology, ordering a stop to use and sales in China and awarding RMB 10 million in damages. Angel can appeal.

finanznachrichten.de4 min
AUG 10
$DDDMed

3D Printing Financials: 3D Systems, Prodways, and Align Build on Positive Momentum - 3DPrint.com

3D Systems reported Q2 revenue of $94.6M, flat YoY, with healthcare up 6.8% and aerospace/defense and data center infrastructure each growing over 20%. Adjusted EBITDA loss narrowed to $0.8M. It expects Q3 revenue of $96M to $99M. Prodways posted Q2 revenue of €10.5M (+5% YoY) and plans a €20M buyback. Align Technology reported record Q2 revenue of just over $1.05B (+4.3%), with clear aligner revenue up 8.2% and 2026 revenue growth guidance of 3% to 4%.

3dprint.com6 min
AUG 8
$ALGNMedAI 9/10

Align Technology (ALGN) Q2 2026 Earnings Call Transcript

Align Technology (ALGN) reported Q2 2026 revenue of $1,056.2 million, up 4.3% y/y, driven by record Clear Aligner volumes and higher ASPs. Clear Aligner revenue rose 8.2% to $870.9 million on 691,785 cases. Systems and Services revenue fell 10.8% to $185.3 million. Q3 revenue guidance is $1.00 to $1.02 billion; full-year growth 3% to 4%.

aol.com7 min